Difference between revisions of "DLA Upstream"

From Powerbase
Jump to: navigation, search
(Notes)
(Clients)
Line 4: Line 4:
 
According to Kevin Craig, of DLA Upstream 'It works with NHS Trusts, American pharmaceutical companies in the UK and has worked with the BIA over the last two years'{{ref|2}}
 
According to Kevin Craig, of DLA Upstream 'It works with NHS Trusts, American pharmaceutical companies in the UK and has worked with the BIA over the last two years'{{ref|2}}
 
*[[British Bankers' Association]], [[Centrica]] and [[Standard Life]]. {{ref|3}}
 
*[[British Bankers' Association]], [[Centrica]] and [[Standard Life]]. {{ref|3}}
*[[Bioindustry Association]] particularly in relation to animal rights campaigns against animal testing.  One of the Associations members is [[Huntingdon Life Sciences]].  [[Paul Gay]] of HLS records
+
*[[Bioindustry Association]] particularly in relation to animal rights campaigns against animal testing.  One of the Associations members is [[Huntingdon Life Sciences]].  [[Paul Gay]] of HLS records (January 21-28 2001):
:January 21-28 2001
 
 
::Enormous thanks go to the BIA and other trade associations for their support and lobbying activity during this time.{{ref|1}}
 
::Enormous thanks go to the BIA and other trade associations for their support and lobbying activity during this time.{{ref|1}}
  

Revision as of 07:07, 22 May 2007

DLA Upstream is the lobbying branch of DLA. They gave more than £5,000 in sponsorship to the Labour Party in 1999-2000 and spent more than £5,000 on "Tickets for Dinners" in 2000-2001.

Clients

According to Kevin Craig, of DLA Upstream 'It works with NHS Trusts, American pharmaceutical companies in the UK and has worked with the BIA over the last two years'[1]

Enormous thanks go to the BIA and other trade associations for their support and lobbying activity during this time.[3]

Affiliations

Notes

  1. ^ PUBLIC POLICY ISSUES: HOW LOBBYING YOUR MP CAN HELP Kevin Craig, DLA Upstream, BIOINDUSTRY ASSOCIATION RISK MANAGEMENT SEMINAR, RISK AND REPUTATION: ANIMAL TESTING – MINIMISING RISK, 2 April 2001, Accessed March 2007.
  2. ^ http://www.lawcareers.net/Information/LCNFocus/Detail.aspx?r=85
  3. ^ THE IMPACT OF THIS ISSUE – EXPERIENCES AT HUNTINGDON Andrew Gay, Marketing Director, Huntingdon Life Sciences, BIOINDUSTRY ASSOCIATION RISK MANAGEMENT SEMINAR, RISK AND REPUTATION: ANIMAL TESTING – MINIMISING RISK, 2 April 2001, Accessed March 2007.